Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hammond

Showing results (441-450 of 448) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 448 results.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearanceTin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of ImmunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Nature Communications|November 12, 2025
Age-impaired remyelination is associated with dysregulated microglial transitionsSameera Zia, Marianela E Traetta, Charbel S Baaklini, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Nature Communications|February 10, 2016
Genomic insights into the Ixodes scapularis tick vector of Lyme diseaseMonika Gulia-Nuss, Andrew B Nuss, Jason M Meyer, et al.
Pageof 45

Showing results (441-450 of 448) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 448 results.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearanceTin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
Annals of Internal Medicine|February 18, 2020
Adverse Effects of Low-Dose Methotrexate: A Randomized TrialDaniel H Solomon, Robert J Glynn, Elizabeth W Karlson, et al.
Science Translational Medicine|January 24, 2024
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Medrxiv : the Preprint Server for Health Sciences|August 14, 2023
SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of ImmunodeficiencyYijia Li, Manish C Choudhary, James Regan, et al.
Nature Communications|November 12, 2025
Age-impaired remyelination is associated with dysregulated microglial transitionsSameera Zia, Marianela E Traetta, Charbel S Baaklini, et al.
Blood|January 27, 2026
Ruxolitinib for Ciltacabtagene Autoleucel-Associated Refractory DiarrheaViktoria Blumenberg, Filippo Birocchi, Angela Shih, et al.
The Lancet. Infectious Diseases|June 20, 2025
Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b studyJohan A Maertens, George R Thompson, Andrej Spec, et al.
Nature Communications|February 10, 2016
Genomic insights into the Ixodes scapularis tick vector of Lyme diseaseMonika Gulia-Nuss, Andrew B Nuss, Jason M Meyer, et al.
Pageof 45